0000899243-20-031964.txt : 20201123 0000899243-20-031964.hdr.sgml : 20201123 20201123190344 ACCESSION NUMBER: 0000899243-20-031964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201119 FILED AS OF DATE: 20201123 DATE AS OF CHANGE: 20201123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Anthony CENTRAL INDEX KEY: 0001606030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 201339475 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-19 0 0000730272 REPLIGEN CORP RGEN 0001606030 Hunt Anthony C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 1 0 0 Chief Executive Officer Common Stock 2020-11-19 4 M 0 20000 26.05 A 253327 D Common Stock 2020-11-19 4 S 0 5447 184.69 D 247880 D Common Stock 2020-11-19 4 S 0 6823 185.67 D 241057 D Common Stock 2020-11-19 4 S 0 6300 186.50 D 234757 D Common Stock 2020-11-19 4 S 0 1430 187.60 D 233327 D Stock Option (Right to Buy) 26.05 2020-11-19 4 M 0 20000 0.00 D 2026-02-26 Common Stock 20000 0 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 11, 2020. $184.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.11 to $185.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $185.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.12 to $186.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $186.50 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.12 to $187.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $187.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.19 to $189.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is currently exercisable. /s/ Jeffrey P. Leduc (Attorney in Fact) 2020-11-23